Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037

Lookup NU author(s): Dr Emma Haagensen, Huw ThomasORCiD, Dr Ross Maxwell, Emeritus Professor Herbie Newell

Downloads

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Haagensen EJ, Thomas HD, Schmalix WA, Payne AC, Kevorkian L, Allen RA, Bevan P, Maxwell RJ, Newell DR

Publication type: Article

Publication status: Published

Journal: Cancer Chemotherapy and Pharmacology

Year: 2016

Volume: 78

Issue: 6

Pages: 1269-1281

Print publication date: 01/12/2016

Online publication date: 11/11/2016

Acceptance date: 31/10/2016

Date deposited: 24/01/2017

ISSN (print): 0344-5704

ISSN (electronic): 1432-0843

Publisher: Springer Berlin Heidelberg

URL: http://dx.doi.org/10.1007/s00280-016-3186-4

DOI: 10.1007/s00280-016-3186-4

Altmetrics

Altmetrics provided by Altmetric

Funding

Funder referenceFunder name
UCB Celltech, Slough, United Kingdom
C240/A7409CRUK Drug Discovery Programme
C240/A7409CRUK Drug Discovery Programme
C240/A7409CRUK Drug Discovery Programme
C240/A7409CRUK Drug Discovery Programme
C240/A7409Cancer Research UK CRUK (open competition)
C240/A7409Cancer Research UK CRUK (open competition)
C240/A7409Cancer Research UK CRUK (open competition)
C240/A7409Cancer Research UK CRUK (open competition)

Share